BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37236648)

  • 1. Anticipatory prescribing in community end-of-life care: systematic review and narrative synthesis of the evidence since 2017.
    Bowers B; Antunes BCP; Etkind S; Hopkins SA; Winterburn I; Kuhn I; Pollock K; Barclay S
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e612-e623. PubMed ID: 37236648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End of life care in UK care homes - controlled drugs: systematic review and narrative synthesis.
    Majumder M; Bowers B; Pollock K; Goodman C; Kuhn I; Barclay S
    BMJ Support Palliat Care; 2022 Jun; ():. PubMed ID: 35768201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unwelcome memento mori or best clinical practice? Community end of life anticipatory medication prescribing practice: A mixed methods observational study.
    Bowers B; Pollock K; Barclay S
    Palliat Med; 2022 Jan; 36(1):95-104. PubMed ID: 34493122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneously reassuring and unsettling: a longitudinal qualitative study of community anticipatory medication prescribing for older patients.
    Bowers B; Pollock K; Barclay S
    Age Ageing; 2022 Dec; 51(12):. PubMed ID: 36477784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticipatory prescribing at the end of life in Lothian care homes.
    Finucane AM; Stevenson B; Gardner H; McArthur D; Murray SA
    Br J Community Nurs; 2014 Nov; 19(11):544-7. PubMed ID: 25381850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPs' decisions about prescribing end-of-life anticipatory medications: a qualitative study.
    Bowers B; Barclay SS; Pollock K; Barclay S
    Br J Gen Pract; 2020 Oct; 70(699):e731-e739. PubMed ID: 32895243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing unplanned hospital admissions from care homes: a systematic review.
    Chambers D; Cantrell A; Preston L; Marincowitz C; Wright L; Conroy S; Lee Gordon A
    Health Soc Care Deliv Res; 2023 Oct; 11(18):1-130. PubMed ID: 37916580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The financial costs of anticipatory prescribing: A retrospective observational study of prescribed, administered and wasted medications using community clinical records.
    Morgan L; Barclay S; Pollock K; Massou E; Bowers B
    Palliat Med; 2023 Dec; 37(10):1554-1561. PubMed ID: 37817429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administering anticipatory medications in end-of-life care: a qualitative study of nursing practice in the community and in nursing homes.
    Wilson E; Morbey H; Brown J; Payne S; Seale C; Seymour J
    Palliat Med; 2015 Jan; 29(1):60-70. PubMed ID: 25070861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous infusion: is community anticipatory prescribing and administration safe?
    Coyle S; Sinden R; Wignall-Coyle J; Benson S; Powell P; Monnery D
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e1373-e1378. PubMed ID: 34815249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out-of-hours services and end-of-life hospital admissions: a complex intervention systematic review and narrative synthesis.
    Papavasiliou E; Hoare S; Bowers B; Kelly MP; Barclay S
    Br J Gen Pract; 2021 Oct; 71(711):e780-e787. PubMed ID: 34489250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticipatory prescribing in terminal care at home: what challenges do community health professionals encounter?
    Faull C; Windridge K; Ockleford E; Hudson M
    BMJ Support Palliat Care; 2013 Mar; 3(1):91-7. PubMed ID: 24644333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative study of community nurses' decision-making around the anticipatory prescribing of end-of-life medications.
    Bowers B; Redsell SA
    J Adv Nurs; 2017 Oct; 73(10):2385-2394. PubMed ID: 28423478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mixed-methods systematic review and meta-analysis of barriers and facilitators to paediatric symptom management at end of life.
    Greenfield K; Holley S; Schoth DE; Harrop E; Howard RF; Bayliss J; Brook L; Jassal SS; Johnson M; Wong I; Liossi C
    Palliat Med; 2020 Jun; 34(6):689-707. PubMed ID: 32228216
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.